Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries

Haematologica. 2013 Oct;98(10):e127-30. doi: 10.3324/haematol.2012.083063. Epub 2013 May 28.
No abstract available

Keywords: combination therapy; hematologic malignancies; invasive fungal infections; lipid formulations of amphotericin B; mucormycosis; posaconazole.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphotericin B / administration & dosage*
  • Antifungal Agents / administration & dosage*
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Hematologic Diseases / drug therapy*
  • Hematologic Diseases / epidemiology
  • Humans
  • Mucormycosis / drug therapy*
  • Mucormycosis / epidemiology
  • Registries*
  • Treatment Outcome
  • Triazoles / administration & dosage*

Substances

  • Antifungal Agents
  • Triazoles
  • liposomal amphotericin B
  • posaconazole
  • Amphotericin B